Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
4.680
-0.580 (-11.03%)
At close: Apr 28, 2026, 4:00 PM EDT
4.825
+0.144 (3.09%)
After-hours: Apr 28, 2026, 7:49 PM EDT
Cingulate Employees
Cingulate had 14 employees as of December 31, 2025. The number of employees increased by 1 or 7.69% compared to the previous year.
Employees
14
Change (1Y)
1
Growth (1Y)
7.69%
Revenue / Employee
n/a
Profits / Employee
-$1,603,565
Market Cap
54.42M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 14 | 1 | 7.69% |
| Dec 31, 2024 | 13 | 0 | - |
| Dec 31, 2023 | 13 | -2 | -13.33% |
| Dec 31, 2022 | 15 | -1 | -6.25% |
| Dec 31, 2021 | 16 | 4 | 33.33% |
| Sep 30, 2021 | 13 | 1 | 8.33% |
| Jun 30, 2021 | 13 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Metagenomi Therapeutics | 119 |
| MindWalk Holdings | 102 |
| BeyondSpring | 44 |
| Cue Biopharma | 29 |
| MiNK Therapeutics | 23 |
| iBio, Inc. | 20 |
| ImageneBio | 15 |
| Instil Bio | 14 |
CING News
- 22 days ago - Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 4Q25 - Newsfile Corp
- 6 weeks ago - Why did Cingulate stock skyrocket today? - Invezz
- 5 months ago - Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 3Q25 - Newsfile Corp
- 6 months ago - Cingulate's Lead ADHD Candidate CTx-1301 Selected for Podium Presentation at AACAP Annual Meeting - GlobeNewsWire
- 7 months ago - Cingulate Secures Exclusive Manufacturing Partnership with Bend Bio Sciences to Support Future Commercialization of Next Generation ADHD Treatment - GlobeNewsWire
- 8 months ago - Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 2Q25 - Newsfile Corp
- 9 months ago - Cingulate Inc. Reports Second Quarter 2025 Financial Results and Provides Recent Highlights - GlobeNewsWire
- 9 months ago - Cingulate Provides Management Team Update - GlobeNewsWire